High-dose intravenous immunoglobulins dramatically reverse systemic capillary leak syndrome

Abstract

Intravenous immunoglobulins were effective against systemic capillary leak syndrome symptoms in three patients, but their exact mechanism remains unknown. Their immunomodulatory effect merits further investigation.